Drug profile · INN
eptotermin alfa
OSIGRAFT
eptotermin alfa (OSIGRAFT) is a bone morphogenetic protein receptor type-1a agonist.
EMA: withdrawn Musculo-skeletal system (M05) M05BC02
Patents linked 0
Pipeline programs 0
News articles 0
Drug details — eptotermin alfa
- Class
- Musculo-skeletal system (M05)
- Route
- —
- Patents
- 0
- Programs
- 0
- Data quality
- 0.83
Quick answer
eptotermin alfa (OSIGRAFT) is a bone morphogenetic protein receptor type-1a agonist.
Key facts
INN eptotermin alfa
Brand OSIGRAFT
Mechanism Bone morphogenetic protein receptor type-1A agonist
Target Activin receptor type-1
Therapeutic class Musculo-skeletal system (M05)
ATC code M05BC02
Mechanism of action
Bone morphogenetic protein receptor type-1A agonist
Primary target: Activin receptor type-1
Approval history
| Authority | Status | Date |
|---|---|---|
| EMA | withdrawn | — |
Related & competitor drugs
Frequently asked questions
What is eptotermin alfa?
eptotermin alfa (OSIGRAFT) is a bone morphogenetic protein receptor type-1a agonist.
What is the brand name for eptotermin alfa?
OSIGRAFT is a marketed brand name for eptotermin alfa. Check FDA Drugs@FDA for the current US label holder and prescribing information.